2024 Midwest Radiation Oncology Symposium: Unlocking Innovations in Cancer Care – AI in Radiation Oncology

SAVE THE DATE! Aug. 23-24, 2024

Join us at the forefront of Artificial Intelligence in Radiation Oncology!

We are thrilled to announce our upcoming symposium dedicated to the dynamic convergence of AI and Radiation Oncology, where cutting-edge technologies meet the intricacies of cancer treatment.

This symposium aims to bring together the brilliant minds of physicians and physicists, fostering an interdisciplinary dialogue that explores the immense potential of AI in revolutionizing radiation oncology.

Our primary objective is to delve into the latest advancements, share groundbreaking research, and discuss collaborative strategies for integrating AI seamlessly into clinical practices.

This symposium is a unique opportunity to explore the intersection of medicine and technology.

Don't miss your chance to be part of a transformative event that accelerates the future of cancer care. Join us as we embark on a journey toward redefining the landscape of AI in Radiation Oncology.

Attendance Options 

In-Person
UNMC Fred & Pamela Buffett Cancer Center – Room 0.12.101
505 S 45th Street, Omaha, NE 68105

Live Stream
Via Zoom – Instructions on how to join the live stream will be sent to registered participants via email a few days before the start of the symposium. 

Accreditation

In support of improving patient care, University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This live activity has been approved for AMA PRA Category 1 Credit™.
This activity has been approved for ANCC contact hours.

Medical Physics Continuing Education Credit (MPCEC), American Society of Radiologic Technologists (ASRT), and Medical Dosimetrist Certification Board (MDCB) credits will also be available.